Increased frequency of anxiety, depression, quality of life and sexual life in young hypogonadotropic hypogonadal males and impacts of testosterone replacement therapy on these conditions

Endocrine Journal

Volumn 59, Issue 12, 2012, Pages 1099-1105

  Aydogan, Umit ^a   Aydogdu, Aydogan ^a   Akbulut, Halil ^a   Sonmez, Alper ^a   Yuksel, Servet ^a   Basaran, Yalcin ^a   Uzun, Ozcan ^a   Bolu, Erol ^a   Saglam, Kenan ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Anxiety; Depression; Hypogonadism; Quality of life; Testosterone

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE; TESTOSTERONE; TESTOSTERONE DECANOATE; TESTOSTERONE ISOCAPROATE; TESTOSTERONE PHENYLPROPIONATE; TESTOSTERONE PROPIONATE; UNCLASSIFIED DRUG;

ADULT; ANDROGEN THERAPY; ANXIETY DISORDER; ARIZONA SEXUAL EXPERIENCES; ARTICLE; BECK ANXIETY INVENTORY; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CONGENITAL HYPOGONADOTROPIC HYPOGONADISM; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; MALE; OUTCOME ASSESSMENT; QUALITY OF LIFE; RATING SCALE; RELIABILITY; SCORING SYSTEM; SEXUAL BEHAVIOR; SHORT FORM 36; TREATMENT DURATION;

ADULT; ANXIETY; CASE-CONTROL STUDIES; DEPRESSION; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; LIFE STYLE; MALE; PREVALENCE; QUALITY OF LIFE; RESEARCH DESIGN; SEXUAL BEHAVIOR; TESTOSTERONE; YOUNG ADULT;

EID: 84872065057     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ12-0134     Document Type: Article

References (26)

1. Araujo AB, Esche GR, Kupelian V, O'Donnell AB, Travison TG, Williams RE, Clark RV, McKinlay JB (2007) Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab 92: 4241-4247.
2. McNicholas TA, Dean JD, Mulder H, Carnegie C, Jones NA (2003) A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function. BJU Int 91: 69-74.
3. Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, Weber T, Berman N, Hull L, Swerdloff RS (2004) Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 89: 2085-2098.
4. Beck AT, Epstein N, Brown G, Steer RA (1998) An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56: 893-897.
5. Blute M, Hakimian P, Kashanian J, Shteynshluyger A, Lee M, Shabsigh R (2009) Erectile dysfunction and testosterone deficiency. Front Horm Res 37: 108-122.
6. Amiaz R, Seidman SN (2008) Testosterone and depression in men. Curr Opin Endocrinol Diabetes Obes 15: 278-283.
7. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM (2010) Task Force, Endocrine Society. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 95: 2536-2559.
8. Shabsigh R, Zakaria L, Anastasiadis AG, Seidman AS (2001) Sexual dysfunction and depression: etiology, prevalence, and treatment. Curr Urol Rep 2: 463-467.
9. Isidori AM, Giannetta E, Gianfrilli D, et al. (2005) Effects of testosterone on sexual function in men: results of a meta-analysis. Clin Endocrinol (Oxf) 63: 381-394.
10. Moncada I (2006) Testosterone and men's quality of life. Aging Male 9: 189-193.
11. Zarrouf FA, Artz S, Griffith J, Sirbu C, Kommor M (2009) Testosterone and depression: systematic review and meta-analysis. J Psychiatr Pract 15: 289-305.
12. Ware JE, Sherbourne CD (1992) The MOS 36-item short form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30: 473-483.
13. Kocyigit H, Aydemir O, Olmez N, Memis A (1999) Reliability and validity of the Turkish version of short form-36 (SF-36): a study in a group of patients with rheumatic diseases. Turk J Drugs Ther 12: 102-106.
14. Beck AT (1961) An inventory for measuring depression. Arch Gen Psychiatry 4: 561-571.
15. Hisli N (1988) A validation study of Beck Depression Inventory. Turk J Psychol 6: 118-126 (In Turkish).
16. Beck AT, Epstein N, Brown G, Steer RA (1988) An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56: 893-897.
17. Ulusoy M, Sahin NH, Erkmen H (1998) Turkish version of the Beck Anxiety Inventory: psychometric properties. J Cogn Psychother 12: 163-172.
18. McGahuey CA, Gelenberg AJ, Laukes CA, Moreno FA, Delgado PL, McKnight KM, Manber R (2000) The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther 26: 25-40.
19. Soykan A (2004) The reliability and validity of Arizona sexual experiences scale in Turkish ESRD patients undergoing hemodialysis. Int J Impot Res 16: 531-534.
20. Grinspoon S, Corcoran C, Stanley T, Baaj A, Basgoz N, Klibanski A (2000) Effects of hypogonadism and testosterone administration on depression indices in HIVinfected men. J Clin Endocrinol Metab 85: 60-65.
21. Bhasin S, Basaria S (2011) Diagnosis and treatment of hypogonadism in men. Best Pract Res Clin Endocrinol Metab 25: 251-270.
22. Albrecht-Betancourt M, Hijazi RA, Cunningham GR (2004) Androgen replacement in men with hypogonadism and erectile dysfunction. Endocrine 23: 143-148.
23. Jockenhövel F, Minnemann T, Schubert M, Freude S, Hübler D, Schumann C, Christoph A, Ernst M (2009) Comparison of long-acting testosterone undecanoate formulation versus testosterone enanthate on sexual function and mood in hypogonadal men. Eur J Endocrinol 160: 815-819.
24. Andrade ES Jr, Clapauch R, Buksman S (2009) Short term testosterone replacement therapy improves libido and body composition. Arq Bras Endocrinol Metabol 53: 996-1004.
25. Veras AB, Nardi AE (2010) The complex relationship between hypogonadism and major depression in a young male. Prog Neuropsychopharmacol Biol Psychiatry 34: 421-422.
26. Seidman SN, Spatz E, Rizzo C, Roose SP (2001) Testosterone replacement therapy for hypogonadal men with major depressive disorder: A randomized, placebocontrolled clinical trial. J Clin Psychiatry 62: 406-412.